Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Meningioma × Octreotide × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 7 Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Stomach Neoplasms 4 Esophageal Neoplasms 4 Carcinoid Tumor 4 Weight Loss 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Diarrhea 3 Carcinoma 3 Breast Neoplasms 3 Acromegaly 3 Vipoma 2 Thymoma 2 Somatostatinoma 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Malnutrition 2 Intestinal Obstruction 2 Insulinoma 2 Glucagonoma 2 Colonic Neoplasms 2 Carcinoma, Islet Cell 2 Adenoma, Islet Cell 2 Zollinger-Ellison Syndrome 1 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vomiting 1

Interventions

Hydroxyurea 4 Imatinib Mesylate 3 Everolimus 3 aldesleukin 2 Temozolomide 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2 Proton Therapy 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Laser Speckle Contrast Imaging 2 Filgrastim 2 Donepezil 2 Cyclophosphamide 2 Carmustine 2 Bortezomib 2 Bevacizumab 2 Aminolevulinic Acid 2 90Y-octreotide, DOTA-Tyr(3)- 2 vatalanib 1 trametinib 1 tozuleristide 1 temsirolimus 1 sonidegib 1 sargramostim 1 ribociclib 1 gallium Ga 68 dotatate 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02333565 2023-05-25

CEVOREM

Assistance Publique Hopitaux De Marseille

Phase 2 Completed

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡